fashion -WSS

fashion

author：entertainment 2025-09-27 19:38:20 - browse：63

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Medicare drug price negotiation’s day in court

explore

WSS

Heart disease in astronauts blamed on cosmic radiation

Physicians aren't 'burning out.' They're suffering from moral injury

The real point of Kenneth Smith’s execution by nitrogen gas

Alnylam reports growth in sales of rare disease treatments

Physicians aren't 'burning out.' They're suffering from moral injury

It costs an awful lot of money to give away a kidney

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

Novo Nordisk to expand supply of Wegovy for U.S. patients

BioMarin wins approval for gene therapy to treat hemophilia A

The a glaring gap in research on serious mental illness and primary care

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

It costs an awful lot of money to give away a kidney

Medicare proposal to cover medical devices draws a mixed reaction

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

In age of alternative facts, a scholarly course on calling out crap

Novo Nordisk to expand supply of Wegovy for U.S. patients

Wikipedia

Covid misinformation case heads to Supreme Court

Cybersecurity threat forces Lurie Children's to take systems offline

Congressmen charge Covid hearing ‘could have been an email’

The lessons of Aduhelm, an Alzheimer's drug that was not to be

It costs an awful lot of money to give away a kidney

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Wikipedia

explore

leisure time

focus